Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cell-autonomous retinoic acid receptor signaling has stage-specific effects on mouse enteric nervous system
Tao Gao, Elizabeth C. Wright-Jin, Rajarshi Sengupta, Jessica B. Anderson, Robert O. Heuckeroth
Tao Gao, Elizabeth C. Wright-Jin, Rajarshi Sengupta, Jessica B. Anderson, Robert O. Heuckeroth
View: Text | PDF
Research Article Gastroenterology

Cell-autonomous retinoic acid receptor signaling has stage-specific effects on mouse enteric nervous system

  • Text
  • PDF
Abstract

Retinoic acid (RA) signaling is essential for enteric nervous system (ENS) development, since vitamin A deficiency or mutations in RA signaling profoundly reduce bowel colonization by ENS precursors. These RA effects could occur because of RA activity within the ENS lineage or via RA activity in other cell types. To define cell-autonomous roles for retinoid signaling within the ENS lineage at distinct developmental time points, we activated a potent floxed dominant-negative RA receptor α (RarαDN) in the ENS using diverse CRE recombinase–expressing mouse lines. This strategy enabled us to block RA signaling at premigratory, migratory, and postmigratory stages for ENS precursors. We found that cell-autonomous loss of RA receptor (RAR) signaling dramatically affected ENS development. CRE activation of RarαDN expression at premigratory or migratory stages caused severe intestinal aganglionosis, but at later stages, RarαDN induced a broad range of phenotypes including hypoganglionosis, submucosal plexus loss, and abnormal neural differentiation. RNA sequencing highlighted distinct RA-regulated gene sets at different developmental stages. These studies show complicated context-dependent RA-mediated regulation of ENS development.

Authors

Tao Gao, Elizabeth C. Wright-Jin, Rajarshi Sengupta, Jessica B. Anderson, Robert O. Heuckeroth

×

Figure 3

Blocking RAR signaling impairs ENCDC migration and differentiation at E10.5. (A and B) Whole embryo imaging showing E10.5 RarαDNLoxP/+ (control) (A) or E10.5 RarαDNLoxP/+; Wnt1Cre+ (B) mice stained with TUJ1 (red) and SOX10 (green) antibodies plus DAPI (blue).

Options: View larger image (or click on image) Download as PowerPoint
Blocking RAR signaling impairs ENCDC migration and differentiation at E1...
Scale bar: 500 μm. (C–J) Zoomed-in images of selected slices from the Z-stack of the whole embryos show esophagus and stomach from control (C–F) or RarαDNLoxP/+; Wnt1Cre+ (G–J) mice. Scale bar: 100 μm. In control embryos, there are readily visible SOX10+TUJ1+ cells in both esophagus and stomach area (C–F). In contrast, there are almost no SOX10+ cells in the mutant stomach, even though SOX10+ cells were observed in the esophagus (G–J). (E and I) White dotted lines outline of esophagus and stomach. Yellow dotted lines highlight the region with extrinsic vagal nerve fibers. E, esophagus; S, stomach. These are representative images from n = 3 RarαDNLoxP/+ (control), n = 3 RarαDNLoxP/+; Wnt1Cre+.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts